Losartan Preserves Erectile Function After Bilateral Cavernous Nerve Injury via Antifibrotic Mechanisms in Male Rats

Journal of Urology

Volumn 181, Issue 6, 2009, Pages 2816-2822

  Canguven, Onder ^a   Lagoda, Gwen ^a   Sezen, Sena F ^a   Burnett, Arthur L ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

angiotensin II; erectile dysfunction; fibrosis; losartan; penis

Indexed keywords

ALPHA ACTIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; FIBRONECTIN; LOSARTAN; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAVERNOUS NERVE INJURY; CONTROLLED STUDY; DRUG MECHANISM; DRUG MEGADOSE; ELECTROSTIMULATION; LOW DRUG DOSE; MALE; MYOFIBROSIS; NERVE INJURY; NONHUMAN; PENILE FIBROSIS; PENIS ERECTION; PRIORITY JOURNAL; RAT; VASCULAR FIBROSIS; VASOCONSTRICTION; WESTERN BLOTTING;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ERECTILE DYSFUNCTION; FIBROSIS; LOSARTAN; MALE; PENIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 67349099471     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.01.097     Document Type: Article

References (20)

1. Burnett A.L., Aus G., Canby-Hagino E.D., Cookson M.S., D'Amico A.V., Dmochowski R.R., et al. Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol 178 (2007) 597
2. User H.M., Hairston J.H., Zelner D.J., McKenna K.E., and McVary K.T. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 169 (2003) 1175
3. El-Sakka A., Yen T.S., Lin C.S., and Lue T.F. Traumatic arteriogenic erectile dysfunction: a rat model. Int J Impot Res 13 (2001) 162
4. Iacono F., Giannella R., Somma P., Manno G., Fusco F., and Mirone V. Histological alterations in cavernous tissue after radical prostatectomy. J Urol 173 (2005) 1673
5. Dzau V.J., and Re R. Tissue angiotensin system in cardiovascular medicine. A paradigm shift?. Circulation 89 (1994) 493
6. Weber M.A. The angiotensin II receptor blockers: opportunities across the spectrum of cardiovascular disease. Rev Cardiovasc Med 3 (2002) 183
7. Kranzhofer R., Schmidt J., Pfeiffer C.A., Hagl S., Libby P., and Kubler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19 (1999) 1623
8. Ruiz-Ortega M., Ruperez M., Esteban V., and Egido J. Molecular mechanisms of angiotensin II-induced vascular injury. Curr Hypertens Rep 5 (2003) 73
9. Belmadani S., Bernal J., Wei C.C., Pallero M.A., Dell'italia L., Murphy-Ullrich J.E., et al. A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II. Am J Pathol 171 (2007) 777
10. Massague J., Blain S.W., and Lo R.S. TGF beta signaling in growth control, cancer, and heritable disorders. Cell 103 (2000) 295
11. Rodriguez-Vita J., Sanchez-Lopez E., Esteban V., Ruperez M., Egido J., and Ruiz-Ortega M. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Circulation 111 (2005) 2509
12. Burnett A.L., and Becker R.E. Immunophilin ligands promote penile neurogenesis and erection recovery after cavernous nerve injury. J Urol 171 (2004) 495
13. Lagoda G., Jin L., Lehrfeld T.J., Liu T., and Burnett A.L. FK506 and sildenafil promote erectile function recovery after cavernous nerve injury through antioxidative mechanisms. J Sex Med 4 (2007) 908
14. Moon J.A., Kim H.T., Cho I.S., Sheen Y.Y., and Kim D.K. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Kidney Int 70 (2006) 1234
15. Kifor I., Williams G.H., Vickers M.A., Sullivan M.P., Jodbert P., and Dluhy R.G. Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum. J Urol 157 (1997) 1920
16. Toblli J.E., Cao G., Lombrana A., and Rivero M. Functional and morphological improvement in erectile tissue of hypertensive rats by long-term combined therapy with phosphodiesterase type 5 inhibitor and losartan. J Sex Med 4 (2007) 1291
17. Habashi J.P., Judge D.P., Holm T.M., Cohn R.D., Loeys B.L., Cooper T.K., et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312 (2006) 117
18. Leungwattanakij S., Bivalacqua T.J., Usta M.F., Yang D.Y., Hyun J.S., Champion H.C., et al. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 24 (2003) 239
19. Hu W.L., Hu L.Q., Li S.W., Zheng X.M., and Tian B.C. Expression of transforming growth factor-beta1 in penile tissue from rats with bilateral cavernosal nerve ablation. BJU Int 94 (2004) 424
20. Brown K.A., Pietenpol J.A., and Moses H.L. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. J Cell Biochem 101 (2007) 9